Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
51.65 Up 2.51(5.11%) 4:00PM EDT
Prev Close:49.14
Open:49.31
Bid:51.11 x 100
Ask:51.64 x 300
1y Target Est:83.80
Beta:0.95
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:49.31 - 52.07
52wk Range:36.82 - 80.42
Volume:622,529
Avg Vol (3m):301,981
Market Cap:1.07B
P/E (ttm):88.59
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDUp 5.11%1.07B
LLYUp 0.83%68.92B
MRKDown 0.55%169.82B
RHHBYDown 0.03%250.09B

Key Statistics

Forward P/E (1 yr):21.34
P/S (ttm):19.11
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.44
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback